Please enable JavaScript to continue using this application.

Compare $SPRO vs $XBIT | Chartloom

Compare

$SPRO vs $XBIT

Spero Therapeutics Inc · XBiotech Inc

SPRO

Spero Therapeutics Inc

XBIT

XBiotech Inc

Compare $SPRO vs $XBIT

Comparing Spero Therapeutics Inc and XBiotech Inc

SPROSpero Therapeutics Inc

XBITXBiotech Inc

SPROSpero Therapeutics Inc

Market cap

$69M

P/E (TTM)

9.42x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-3.3%

YTD performance

-48.9%

52W performance

-47.4%

FCF yield

28.2%

XBITXBiotech Inc

Market cap

$70M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.8%

52W performance

-14.9%

FCF yield

-58.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SPRO

XBIT

Detailed metrics comparison

SPRO

Spero Therapeutics Inc

XBIT

XBiotech Inc

Market Cap

SPRO$69M

XBIT$70M

Enterprise Value

SPRO$19M

XBIT$-40M

Price

SPRO$1.20

XBIT$2.29

P/E Ratio

SPRO9.42x

XBITN/A

P/S Ratio

SPRO1.48x

XBIT16.50x

EV/Sales

SPRO0.40x

XBIT-10.81x

EV/EBITDA

SPRO0.78x

XBIT-0.06x

P/B Ratio

SPRO1.57x

XBIT0.52x

P/FCF Ratio

SPRO3.55x

XBITN/A

EV/FCF

SPRO0.96x

XBIT0.97x

PEG Ratio

SPRON/A

XBITN/A

Forward P/E (NTM)

SPRON/A

XBITN/A

Forward P/S (NTM)

SPRON/A

XBITN/A

Revenue (TTM)

SPRO$47M

XBIT$0

Revenue Growth (YoY)

SPRO-3.3%

XBITN/A

Forward Rev Growth

SPRO300.0%

XBIT0.0%

Gross Margin (TTM)

SPRO0.0%

XBIT83.8%

Operating Margin (TTM)

SPRO22.1%

XBIT0.0%

EBITDA Margin (TTM)

SPRO51.2%

XBIT0.0%

Net Margin (TTM)

SPRO15.7%

XBIT0.0%

FCF Margin (TTM)

SPRO41.7%

XBITN/A

Net Income (TTM)

SPRO$7M

XBIT$-45M

FCF (TTM)

SPRO$20M

XBIT$-41M

EPS (TTM)

SPRO$0.13

XBIT-$1.48

ROE (TTM)

SPRO16.2%

XBIT-3162.0%

ROA (TTM)

SPRO12.6%

XBIT-3029.0%

ROIC (TTM)

SPRO16.2%

XBIT-3162.0%

Cash

SPRO$51M

XBIT$110M

Debt

SPRO$0

XBIT$0

Net Cash/Debt

SPRO$51M

XBIT$110M

Current Ratio (TTM)

SPRO6.12x

XBIT33.15x

Quick Ratio (TTM)

SPRO6.03x

XBIT32.75x

Debt/Equity (TTM)

SPRO0.00x

XBIT0.00x

Debt/Assets (TTM)

SPRO0.0%

XBIT0.0%

Interest Coverage (TTM)

SPRON/A

XBITN/A

Net Debt/EBITDA (TTM)

SPRO0.00x

XBIT0.00x

Beta

SPRO1.54

XBIT0.73

52W Performance

SPRO-47.4%

XBIT-14.9%

YTD Performance

SPRO-48.9%

XBIT-3.8%

% from 52W High

SPRO-61.0%

XBIT-33.4%

% from 52W Low

SPRO11.1%

XBIT9.6%

Asset Turnover (TTM)

SPRO1.00x

XBIT0.02x

FCF Yield (TTM)

SPRO28.2%

XBIT-58.5%

Earnings Yield (TTM)

SPRO10.6%

XBIT-64.6%

Dividend Yield (TTM)

SPRON/A

XBITN/A

Rule of 40

SPRO38.4

XBIT0.0

EV/GP/RG

SPRON/A

XBITN/A

Ticker research

View SPRO research View XBIT research

Metric	SPRO Spero Therapeutics Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$69M	$70M
Enterprise Value	$19M	$-40M
Price	$1.20	$2.29
P/E Ratio	9.42x	N/A
P/S Ratio	1.48x	16.50x
EV/Sales	0.40x	-10.81x
EV/EBITDA	0.78x	-0.06x
P/B Ratio	1.57x	0.52x
P/FCF Ratio	3.55x	N/A
EV/FCF	0.96x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$47M	$0
Revenue Growth (YoY)	-3.3%	N/A
Forward Rev Growth	300.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	22.1%	0.0%
EBITDA Margin (TTM)	51.2%	0.0%
Net Margin (TTM)	15.7%	0.0%
FCF Margin (TTM)	41.7%	N/A
Net Income (TTM)	$7M	$-45M
FCF (TTM)	$20M	$-41M
EPS (TTM)	$0.13	-$1.48
ROE (TTM)	16.2%	-3162.0%
ROA (TTM)	12.6%	-3029.0%
ROIC (TTM)	16.2%	-3162.0%
Financial Health
Cash	$51M	$110M
Debt	$0	$0
Net Cash/Debt	$51M	$110M
Current Ratio (TTM)	6.12x	33.15x
Quick Ratio (TTM)	6.03x	32.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	0.73
52W Performance	-47.4%	-14.9%
YTD Performance	-48.9%	-3.8%
% from 52W High	-61.0%	-33.4%
% from 52W Low	11.1%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	1.00x	0.02x
FCF Yield (TTM)	28.2%	-58.5%
Earnings Yield (TTM)	10.6%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	38.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View SPRO research	View XBIT research

Valuation

P/E Ratio

SPRO

9.42x

P/S Ratio

SPRO

1.48x

XBIT

16.50x

EV/FCF

SPRO

0.96x

XBIT

0.97x

Growth & revenue

Revenue Growth TTM

SPRO

-3.3%

Forward Revenue Growth

SPRO

300.0%

XBIT

0.0%

Profitability & performance

Gross Margin

XBIT

83.8%

SPRO

0.0%

ROE

SPRO

16.2%

XBIT

-3162.0%

FCF Yield %

SPRO

28.2%

XBIT

-58.5%

52-Week Performance

XBIT

-14.9%

SPRO

-47.4%

Detailed metrics comparison

SPRO

Spero Therapeutics Inc

XBIT

XBiotech Inc

Market Cap

SPRO$69M

XBIT$70M

Enterprise Value

SPRO$19M

XBIT$-40M

Price

SPRO$1.20

XBIT$2.29

P/E Ratio

SPRO9.42x

XBITN/A

P/S Ratio

SPRO1.48x

XBIT16.50x

EV/Sales

SPRO0.40x

XBIT-10.81x

EV/EBITDA

SPRO0.78x

XBIT-0.06x

P/B Ratio

SPRO1.57x

XBIT0.52x

P/FCF Ratio

SPRO3.55x

XBITN/A

EV/FCF

SPRO0.96x

XBIT0.97x

PEG Ratio

SPRON/A

XBITN/A

Forward P/E (NTM)

SPRON/A

XBITN/A

Forward P/S (NTM)

SPRON/A

XBITN/A

Revenue (TTM)

SPRO$47M

XBIT$0

Revenue Growth (YoY)

SPRO-3.3%

XBITN/A

Forward Rev Growth

SPRO300.0%

XBIT0.0%

Gross Margin (TTM)

SPRO0.0%

XBIT83.8%

Operating Margin (TTM)

SPRO22.1%

XBIT0.0%

EBITDA Margin (TTM)

SPRO51.2%

XBIT0.0%

Net Margin (TTM)

SPRO15.7%

XBIT0.0%

FCF Margin (TTM)

SPRO41.7%

XBITN/A

Net Income (TTM)

SPRO$7M

XBIT$-45M

FCF (TTM)

SPRO$20M

XBIT$-41M

EPS (TTM)

SPRO$0.13

XBIT-$1.48

ROE (TTM)

SPRO16.2%

XBIT-3162.0%

ROA (TTM)

SPRO12.6%

XBIT-3029.0%

ROIC (TTM)

SPRO16.2%

XBIT-3162.0%

Cash

SPRO$51M

XBIT$110M

Debt

SPRO$0

XBIT$0

Net Cash/Debt

SPRO$51M

XBIT$110M

Current Ratio (TTM)

SPRO6.12x

XBIT33.15x

Quick Ratio (TTM)

SPRO6.03x

XBIT32.75x

Debt/Equity (TTM)

SPRO0.00x

XBIT0.00x

Debt/Assets (TTM)

SPRO0.0%

XBIT0.0%

Interest Coverage (TTM)

SPRON/A

XBITN/A

Net Debt/EBITDA (TTM)

SPRO0.00x

XBIT0.00x

Beta

SPRO1.54

XBIT0.73

52W Performance

SPRO-47.4%

XBIT-14.9%

YTD Performance

SPRO-48.9%

XBIT-3.8%

% from 52W High

SPRO-61.0%

XBIT-33.4%

% from 52W Low

SPRO11.1%

XBIT9.6%

Asset Turnover (TTM)

SPRO1.00x

XBIT0.02x

FCF Yield (TTM)

SPRO28.2%

XBIT-58.5%

Earnings Yield (TTM)

SPRO10.6%

XBIT-64.6%

Dividend Yield (TTM)

SPRON/A

XBITN/A

Rule of 40

SPRO38.4

XBIT0.0

EV/GP/RG

SPRON/A

XBITN/A

Ticker research

View SPRO research View XBIT research

Metric	SPRO Spero Therapeutics Inc	XBIT XBiotech Inc
Market & Valuation
Market Cap	$69M	$70M
Enterprise Value	$19M	$-40M
Price	$1.20	$2.29
P/E Ratio	9.42x	N/A
P/S Ratio	1.48x	16.50x
EV/Sales	0.40x	-10.81x
EV/EBITDA	0.78x	-0.06x
P/B Ratio	1.57x	0.52x
P/FCF Ratio	3.55x	N/A
EV/FCF	0.96x	0.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$47M	$0
Revenue Growth (YoY)	-3.3%	N/A
Forward Rev Growth	300.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	22.1%	0.0%
EBITDA Margin (TTM)	51.2%	0.0%
Net Margin (TTM)	15.7%	0.0%
FCF Margin (TTM)	41.7%	N/A
Net Income (TTM)	$7M	$-45M
FCF (TTM)	$20M	$-41M
EPS (TTM)	$0.13	-$1.48
ROE (TTM)	16.2%	-3162.0%
ROA (TTM)	12.6%	-3029.0%
ROIC (TTM)	16.2%	-3162.0%
Financial Health
Cash	$51M	$110M
Debt	$0	$0
Net Cash/Debt	$51M	$110M
Current Ratio (TTM)	6.12x	33.15x
Quick Ratio (TTM)	6.03x	32.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.54	0.73
52W Performance	-47.4%	-14.9%
YTD Performance	-48.9%	-3.8%
% from 52W High	-61.0%	-33.4%
% from 52W Low	11.1%	9.6%
Efficiency & Yields
Asset Turnover (TTM)	1.00x	0.02x
FCF Yield (TTM)	28.2%	-58.5%
Earnings Yield (TTM)	10.6%	-64.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	38.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View SPRO research	View XBIT research